Remodelling of peripheral lung tissue in COPD Source: Eur Respir J 2008; 31: 913-914 Year: 2008
Measurement of in situ inflammatory cell activity in the lungs of patients with COPD or asthma Source: Eur Respir J 2002; 20: Suppl. 38, 267s Year: 2002
Characterization of lung volumes in COPD Source: Virtual Congress 2021 – Biomarkers to phenotype COPD: prediction of exacerbations Year: 2021
Changes in lung function in acute COPD Source: Eur Respir J 2003; 22: Suppl. 45, 239s Year: 2003
Increased serum α1-antitrypsin level in COPD patients with predominant lung emphysema Source: Eur Respir J 2001; 18: Suppl. 33, 248s Year: 2001
Lung and serum biomarkers of tissue lesions due to acute exacerbation of COPD Source: Annual Congress 2012 - Scores, biomarkers and risk factors in respiratory infections Year: 2012
Lung nodules in a lung cancer screening program: incidence density of lung cancer in patients with COPD and/or emphysema Source: Annual Congress 2009 - Epidemiology and management of lung cancer Year: 2009
Altered interaction of respiratory muscle activity, flow and lung volume in infants with chronic lung disease compared to healthy controls Source: Annual Congress 2008 - Respiratory physiology in health and disease Year: 2008
Morphology of pulmonary tissue in patients with COPD Source: Eur Respir J 2003; 22: Suppl. 45, 456s Year: 2003
Comparison of the neutrophils oxidative activity in patients with occupational lung diseases and COPD Source: Eur Respir J 2003; 22: Suppl. 45, 119s Year: 2003
A comparison between total lung capacity and effective alveolar volume in patients with restrictive lung disease Source: Eur Respir J 2005; 26: Suppl. 49, 180s Year: 2005
Inflammation biomarkers of lung tissue damage in acute exacerbation of COPD patients Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections Year: 2013
Lung function and exercise capacity in COPD phenotypes with and without emphysema Source: Virtual Congress 2020 – Burden and predictive factors for chronic lung diseases and comorbidity Year: 2020
Lung function measurements versus structural lung disease in CF Source: Breathe 2008; 5: 65 Year: 2008
Decreasing of lung function in patients with chronically obstructive lung diseases as effect of damage of bronchial mucosa cilia Source: Eur Respir J 2003; 22: Suppl. 45, 416s Year: 2003
Possible mechanisms of protection of lung tissue in smokers without COPD Source: Annual Congress 2007 - Unravelling molecular mysteries of COPD Year: 2007
Lung volume reduction coil treatment restores lung compliance in patients with homogeneous emphysema Source: Annual Congress 2013 –Bronchoscopic treatment of COPD and asthma: where are we going? Year: 2013
Respiratory work and its components during exercise in interstitial lung disease, COPD and controls Source: International Congress 2015 – Respiratory muscles and airways function: from physiology to clinical implications Year: 2015
Measurement of lung diffusion in obstructive lung disease Source: Annual Congress 2004 - PG13 - Lung diffusion measurements in diseases Year: 2004
Lung compliance in patients with pulmonary fibrosis with normal lung volumes Source: Eur Respir J 2007; 30: Suppl. 51, 577s Year: 2007